Kymera Therapeutics (KYMR) EBT Margin Growth (1y) (2020 - 2026)
Kymera Therapeutics (KYMR) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 813.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.12 Bn | - | -55,098.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55,098.00 |
| Dec 31, 2025 | -231,862.00 |
| Sep 30, 2025 | -647,855.00 |
| Jun 30, 2025 | -148,572.00 |
| Mar 31, 2025 | 94,891.00 |
| Dec 31, 2024 | -71,296.00 |
| Sep 30, 2024 | -199,451.00 |
| Jun 30, 2024 | 59,002.00 |
| Mar 31, 2024 | -64,974.00 |
| Dec 31, 2023 | -13,972.00 |
| Sep 30, 2023 | -293,280.00 |
| Jun 30, 2023 | -26,964.00 |
| Mar 31, 2023 | 56,316.00 |
| Dec 31, 2022 | -1,670.00 |
| Sep 30, 2022 | 34,076.00 |
| Jun 30, 2022 | 45,606.00 |
| Mar 31, 2022 | -79,441.00 |
| Dec 31, 2021 | -12,281.00 |
| Sep 30, 2021 | -28,189.00 |
| Jun 30, 2021 | -76,494.00 |